All Posts Archives - Page 2 of 10 - EverGlade Consulting

All Posts

ARPA-H_RAPID rare disease diagnostics

RAPID Solicitation

RAPID_SOL_25_119_FINAL Overview The Advanced Research Projects Agency for Health (ARPA-H) recently announced the newly approved program for Rare disease AI/ML for Precision Integrated Diagnostics (RAPID). The RAPID program aims to significantly improve outcomes for people with rare diseases by reducing diagnostic delays by ≥50%, decreasing misdiagnosis rates, and expanding access to diagnostics. Beyond benefitting the treatment experience of […]

RAPID Solicitation Read More »

Court Blocks NIH Cap Indirect Cost Rate

Court Blocks NIH Cap on Indirect Cost Rates

Court Blocks NIH Cap on Indirect Cost Rates for Government Contracts In a significant development for research institutions and federal contractors, a federal judge has temporarily blocked the National Institutes of Health (NIH) from enforcing its cap on indirect cost rates. This decision comes as a result of a temporary restraining order (TRO) issued by

Court Blocks NIH Cap on Indirect Cost Rates Read More »

Safe Lithium-Ion Battery Development DOE

Safe Lithium-Ion Battery Development

Lithium Ion Battery Development Overview of the Solicitation The Department of Energy (DOE) and affiliates have released a Request for Proposals (RFP) for the development of a safe lithium-ion battery. This initiative aims to create a backup energy storage system capable of providing 2.4 MW*hrs of usable energy while ensuring a robust safety posture. The

Safe Lithium-Ion Battery Development Read More »

NIH Supplemental Guidance

Understanding the NIH Supplemental Guidance on Indirect Cost Rates

Overview The National Institutes of Health (NIH) has issued Supplemental Guidance to the 2024 NIH Grants Policy Statement regarding Indirect Cost Rates (NOT-OD-25-068). This update introduces a standardized 15% indirect cost rate for all applicable grants, aiming to streamline financial policies and enhance funding efficiency for research institutions. Purpose of the Guidance The primary objective

Understanding the NIH Supplemental Guidance on Indirect Cost Rates Read More »

US Capitol building silhouette on blue paint texture

Review of Federal Funding: What It Means and What Comes Next for Life Sciences Organizations

On January 27 and January 28, the Office of Management and Budget (OMB) issued guidance as follows: Memorandum M-25-13, an executive directive halting all federal financial assistance programs as agencies reevaluate spending priorities. An Excel file titled Federal Financial Assistance Program Analysis Template Additional Guidance with Q&A OMB Memorandum M-25-13 Published on January 27, 2025,

Review of Federal Funding: What It Means and What Comes Next for Life Sciences Organizations Read More »

molecular science DARPA

Unlocking the Future of Microsystems: DARPA’s MICA Program

DARPA, Microsystems Induced CAtalysis (MICA) Program Overview of the MICA Program The Defense Advanced Research Projects Agency (DARPA) has recently announced a groundbreaking funding opportunity, titled “Microsystems Induced CAtalysis” (MICA). This Broad Agency Announcement (BAA) aims to enhance molecular science by creating advanced tools and techniques for controlling molecular catalysts using microsystems. This initiative goes

Unlocking the Future of Microsystems: DARPA’s MICA Program Read More »

antiviral therapeutics against filoviruses

New Opportunities with DRIVe: ReBooT and RePAIR Amendments

Amendment 034 – DRIVe EZ BAA_ReBooT_RePAIR New Opportunities with DRIVe: ReBooT and RePAIR Amendments The Biomedical Advanced Research and Development Authority’s (BARDA) Division of Research, Innovation & Ventures (DRIVe) has announced updates to its Easy Broad Agency Announcement (EZ-BAA) with Amendment #034. This amendment reopens and revises the ReBooT (AOI #22) program and pauses the

New Opportunities with DRIVe: ReBooT and RePAIR Amendments Read More »

R&D Funding in Life Sciences: What's Ahead in Trump 2.0?

Webinar Alert: R&D Funding in Life Sciences: What’s Ahead in Trump 2.0?

What to Expect in the Webinar: Federal Programs at Risk: Explore which key life sciences programs might face funding challenges in a new Trump administration. Emerging Opportunities: Learn about research areas poised to gain new momentum and potential funding in the evolving political landscape. Key Players Shaping Change: Get insights into the policymakers and influencers

Webinar Alert: R&D Funding in Life Sciences: What’s Ahead in Trump 2.0? Read More »

EverGlade Consulting

Unlocking Federal Opportunities for AI & Technology Innovators

Securing federal funding is more than a financial boost – it’s a strategic move that positions your company as a leader in innovation. EverGlade Consulting’s proven process helps small and medium-sized AI and tech firms navigate complex federal funding landscapes. Our process works because we focus on your business goals, not just technical details, ensuring

Unlocking Federal Opportunities for AI & Technology Innovators Read More »

Leveraging AI to Enhance Business Intelligence

Leveraging AI to Enhance Business Intelligence

DOD’s New Initiative_AOI Solicitation Leveraging AI to Enhance Business Intelligence: The DoD’s New Initiative The Department of Defense (DoD) has identified a critical need to modernize business intelligence assessments to keep pace with evolving challenges in due diligence evaluations and industrial foreign influence analyses. To address this, the Defense Innovation Unit (DIU) has released an

Leveraging AI to Enhance Business Intelligence Read More »

ARPA-H_EIH health and biomedical research

Emerging Health Innovators (EHI) Initiative

ARPA_H_SOL_25_118_EHI_Solicitation (1) Emerging Health Innovators Solicitation: An Opportunity to Revolutionize Health Innovation The Advanced Research Projects Agency for Health (ARPA-H) has issued the Emerging Health Innovators (EHI) Initiative Solicitation (ARPA-H-SOL-25-118), a groundbreaking funding opportunity aimed at empowering both early-career researchers and community innovators to advance health and biomedical research. Through the EHI Initiative, ARPA-H seeks

Emerging Health Innovators (EHI) Initiative Read More »

MTEC RPP medical techniques, knowledge products, and materials

EverGlade Consulting Funding Alert: MTEC Fiscal Year 2025 Multi-Topic Request for Project Proposals

MTEC-25-04-MultiTopic-RPP_Final Overview of the Solicitation The Medical Technology Enterprise Consortium (MTEC) has recently announced its Fiscal Year 2025 Multi-Topic Request for Project Proposals (RPP). This RPP focuses on eleven key Focus Areas to stimulate innovative medical prototype, technological, and knowledge solutions with military relevance. The RPP targets the following focus areas: Focus Area 1 –

EverGlade Consulting Funding Alert: MTEC Fiscal Year 2025 Multi-Topic Request for Project Proposals Read More »

Scroll to Top